Category Archives: Uncategorized

NYT expose: lobbyist money influencing state attorneys general to drop investigations and enforcement

Attorneys general are now the object of aggressive pursuit by lobbyists and lawyers who use campaign contributions, personal appeals at lavish corporate-sponsored conferences and other means to push them to drop investigations, change policies, negotiate favorable settlements or pressure federal regulators, an investigation by The New York Times has found. For instance, the Times reports: […]

Truth in Lending Act recission case set for oral argument on Tuesday

In light of our post earlier today, I'm reminding our readers that Jesinoski v. Countrywide Home Loan is scheduled for oral argument in the Supreme Court next Tuesday, November 4. Here's the question presented: Does a borrower exercise his right to rescind a transaction in satisfaction of the requirements of Section 1635 by “notifying the […]

How does a consumer exercise her right to recission under the Truth in Lending Act?

The Truth in Lending Act gives consumers the right to rescind many (but not all) consumer-credit transactions under specified circumstances. The courts have disagreed over how a consumer must notify the lender that she is exercising her recission right. That's the topic of Avoiding the Nuclear Option: Balancing Borrower and Lender Rights Under the Truth […]

American Banker Report on Campaign Contributions by the Financial Industry

Here. An excerpt: There's been a concerted move to the right by the banking industry since the passage of the Dodd-Frank Act in 2010. The industry already tilted slightly Republican for years, but there's been a more distinctive shift over the past two election cycles. Employees and PACs representing the financial sector have given 62% […]

Liability (or not) for injuries from generic drugs

Following up on our recent post about whether state law permits brand-name drug manufacturers to be held liable for injuries caused by mislabeled generic drugs, take a look at Who (If Anyone) Should Be Liable for Injuries from Generic Drugs? by law professors Ezra Friedman and Abraham Wickelgren. Here is the abstract: Two recent Supreme […]

Alabama Supreme Court and Sixth Circuit weigh in on whether plaintiffs injured by generic drugs may recover from brand-name drug manufacturers

Back in January 2013, we told you about the ruling of the Alabama Supreme Court in Wyeth v. Weeks. Weeks held that, under Alabama state law, a patient harmed by a generic drug may recover from the brand-name drug manufacturer (on whose branded drug the generic drug is based) for failing to warn about the […]

On-Line Arbitration Clauses Common, NYT Reports

The furor last spring over General Mills's attempt to require anyone who used its websites to arbitrate all claims against the company, which led to a highly publicized return to sanity by the company, hasn't deterred on-line retailers from using both "browsewrap" and "clickwrap" contract terms requiring arbitration of claims arising out of on-line transactions. […]